Clinical Trial Update: Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous bone marrow stromal cell and endothelial progenitor cell transplantation in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Autologous bone marrow stromal cells (bone marrow stromal cells)
• Endothelial progenitor cells (endothelial progenitor cells)

Snippet

Sponsor: Southern Medical University, China | Conditions: Stroke, Infarction, Middle Cerebral Artery | Phase 1, Phase 2 | Status: COMPLETED